You are not logged in.
EFFISOY
What is Effisoy?
Advantages of Effisoy
The Effisoy Story
Product Comparisons
Recommendations
Natural Menopause Relief
AGLYMAX
What is Aglymax?
The AglyMax Process
Koji Fermentation
Isoflavones
Antioxidants
Health Benefits of Fermentation
Aglymax Research
CLINICAL TRIAL
Clinical Trial Validates AglyMax
From BIDMC, Harvard Medical School, Boston, MA
MENOPAUSE
What is Menopause?
34 menopause symptoms
Stages of Menopause
Natural Remedies for Menopause
Pharmaceutical Options
Lifestyle Choices
Role of Hormones
HEALTH TOPICS
Hot Flashes
Night Sweats
Mood Support
Energy Support
Breast Health
Bone Health
Prostate Health
Immune Support
Heart Health
Headaches
Metabolism Support
Sleep Health
RESOURCES
Ask The Expert
FAQs
Our Newsletter
Doctor Testimonials
Testimonials
Submit Your Own Testimonial
Contact Us
Glossary
Articles
Special Offers
You have
0
items
Login
|
Register
|
My Account
Home
|
Contact Us
|
Testimonials
|
Guarantee
|
Privacy/Security
|
Terms
|
Shipping
|
Returns
What is AglyMax?
>
What is AglyMax®?
AglyMax, the primary ingredient in Effisoy, is a unique soy germ extract with standardized levels of isoflavones in their most usable form (aglycones). While the process to produce AglyMax is quite involved and protected by patents in both Japan and the United States, the fundamental technique has existed for thousands of years.
AglyMax was developed to maximize the benefits obtainable from the soy bean. Researchers have found that the key to unlocking soy’s potential was in the selective use of soy germ and its subsequent fermentation by
Koji
. After fermentation, an extraction process is further applied to standardize the active ingredients for maximum benefit.
As a well researched ingredient
, AglyMax has achieved great success and is trusted by many Japanese women and used by large nutritional supplement companies in Japan.
To further validate the benefits of AglyMax on menopausal symptoms for women in the United States, clinical studies were undertaken at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School.
The initial open-label, Pilot Study included 24 menopausal women with five to fourteen hot flashes/day who took an AglyMax supplement daily over an eight-week period. The 21 participants who completed the study experienced an average 54% reduction in their hot flash score which represents improvements in both severity and frequency of hot flashes. The results of this study were published in the International Journal of Gynecology & Obstetrics
.
The successful Pilot Study has since been followed up with a larger scale, randomized, double-blind, placebo-controlled trial at the same facilities. We are pleased to announce that results from the follow up clinical trial have been published in the peer-reviewed medical journal
Menopause
(January 2008). The study found that Effisoy’s active ingredient AglyMax, is effective in reducing hot flashes in menopausal women. The findings showed a 52% reduction in the number of hot flashes over a twelve week period, and, furthermore, there were no negative side effects found among the patients who took the AglyMax soy supplement
(click here to view more detailed results from the clinical trial)
.
SEARCH
> Site Map
Clinically Proven.
Effisoy with Aglymax is clinically proven relief for the uncomfortable symptoms of menopause.
BUY EFFISOY NOW!
How did you hear about Effisoy?
< select >
Recommended By Someone
Magazine
TV
Radio
Newspaper
Spirit of Women
Website
Internet Search
Direct Mail
Other
Statements and/or claims made on this website concerning ingredients or products and their function on the body have not been evaluated by the Food and Drug Administration. This dietary supplement product or any of the claims made in this website are not intended to diagnose, treat, cure or prevent any disease.
Website design by
Papugai
, copyright © 2008 FermaHealth
E-commerce software, SmartCommerce.NET™, copyright © 2008
Papugai, Inc.
All rights reserved.